Increased peripheral blood normal myeloid progenitor cells (CFU-GM) in chronic lymphocytic leukemia: A perspective for autologous peripheral blood stem cell transplantation
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 54 (4) , 235-240
- https://doi.org/10.1111/j.1600-0609.1995.tb00677.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemiaBlood, 1993
- Peripheral Blood Stem Cell Transplantations: Past, present and futureThe International Journal of Cell Cloning, 1993
- Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]Blood, 1992
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.Journal of Clinical Oncology, 1989
- 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaBlood, 1988
- Chronic Leukemias: Oncogenes, Chromosomes, and Advances in TherapyAnnals of Internal Medicine, 1986
- Circulating autologous stem cells collected in very early remission from acute non‐lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapyBritish Journal of Haematology, 1985